(19)

(11)

EP 3 897 604 A1

(12)

(43) Date of publication: 27.10.2021 Bulletin 2021/43 (21) Application number: 19898484.1 (22) Date of filing: 20.03.2019

(51) International Patent Classification (IPC):  A61K 31/17(2006.01) A61K 31/325(2006.01) A61K 47/12(2006.01) A61K 31/201(2006.01) A61K 31/34(2006.01) A61K 47/14(2017.01) (52) Cooperative Patent Classification (CPC): A61K 9/0014; A61K 31/137; A61K 31/325; A61K 31/4174; A61K 31/454; A61K 47/10; A61K 47/12; A61K 47/18; A61K 47/26 (86) International application number: PCT/US2019/023203 (87) International publication number: WO 2020/131147 (25.06.2020 Gazette 2020/26)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 19.12.2018 US 201816225980 (71) Applicant: Marlinz Pharma, LLC Houston, TX 77084 (US)	(72) Inventors: FORRESTER, Perry Houston, TX 77084 (US) SCOTT, Joshua Houston, TX 77084 (US) (74) Representative: Müller Schupfner & Partner Patent- und Rechtsanwaltspartnerschaft mbB  Schellerdamm 19 21079 Hamburg 21079 Hamburg (DE)